Szarkóma trials, also abroad
604 open Szarkóma trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Ország | Open trials |
|---|---|
| Egyesült Államok | 301 |
| Kína | 106 |
| Franciaország | 71 |
| Olaszország | 52 |
| Spanyolország | 39 |
| All other countries |
The same trial often runs in several countries
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004) has 5 sites in Chile and runs in 30 countries. If a site near you is full, another one may still take people.
See A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004) in all 30 countries